Sentence: Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma .
Drug combination annotation:
[{'class': 'NEG', 'spans': ['nivolumab', 'ipilimumab'], 'is_context_needed': True}]